Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for TEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -19.14M
March 31, 2026 -83.57M
December 31, 2025 -43.12M
September 30, 2025 -127.89M
June 30, 2025 34.65M
March 31, 2025 -109.00M
December 31, 2024 -47.21M
September 30, 2024 48.62M
June 30, 2024 -105.09M
Date Value
March 31, 2024 -107.49M
December 31, 2023 -42.98M
September 30, 2023 -68.98M
June 30, 2023 -64.50M
March 31, 2023 -72.49M
December 31, 2022
December 31, 2021 -66.08M
September 30, 2021
December 31, 2020 -46.94M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Personalis, Inc. -29.55M
10X Genomics, Inc. 15.39M
Twist Bioscience Corp. -8.648M
Alamar Biosciences, Inc. (California) -15.07M
IQVIA Holdings, Inc. 360.00M